EKSO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
EKSO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-06-08), Ekso Bionics Holdings's current share price is $1.10. Ekso Bionics Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $3.17. Ekso Bionics Holdings's Cyclically Adjusted PB Ratio for today is 0.35.
The historical rank and industry rank for Ekso Bionics Holdings's Cyclically Adjusted PB Ratio or its related term are showing as below:
During the past years, Ekso Bionics Holdings's highest Cyclically Adjusted PB Ratio was 10.11. The lowest was 0.35. And the median was 3.14.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Ekso Bionics Holdings's adjusted book value per share data for the three months ended in Mar. 2024 was $0.776. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.17 for the trailing ten years ended in Mar. 2024.
The historical data trend for Ekso Bionics Holdings's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ekso Bionics Holdings Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted PB Ratio | Get a 7-Day Free Trial | 3.28 | 2.64 | 1.28 | 4.20 | 0.43 |
For the Medical Instruments & Supplies subindustry, Ekso Bionics Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Ekso Bionics Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Ekso Bionics Holdings's Cyclically Adjusted PB Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
Ekso Bionics Holdings's Cyclically Adjusted PB Ratio for today is calculated as
Cyclically Adjusted PB Ratio | = | Share Price | / | Cyclically Adjusted Book per Share |
= | 1.10 | / | 3.17 | |
= | 0.35 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ekso Bionics Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, Ekso Bionics Holdings's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:
Adj_Book | = | Book Value per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 0.776 | / | 131.7762 | * | 131.7762 | |
= | 0.776 |
Current CPI (Mar. 2024) = 131.7762.
Ekso Bionics Holdings Quarterly Data
Book Value per Share | CPI | Adj_Book | |
201406 | -18.694 | 100.560 | -24.497 |
201409 | -6.106 | 100.428 | -8.012 |
201412 | 18.181 | 99.070 | 24.183 |
201503 | 15.169 | 99.621 | 20.065 |
201506 | 11.057 | 100.684 | 14.472 |
201509 | 7.319 | 100.392 | 9.607 |
201512 | 6.785 | 99.792 | 8.960 |
201603 | 5.010 | 100.470 | 6.571 |
201606 | 1.103 | 101.688 | 1.429 |
201609 | 4.452 | 101.861 | 5.759 |
201612 | 3.453 | 101.863 | 4.467 |
201703 | -0.731 | 102.862 | -0.936 |
201706 | 0.731 | 103.349 | 0.932 |
201709 | 7.429 | 104.136 | 9.401 |
201712 | 5.353 | 104.011 | 6.782 |
201803 | 3.688 | 105.290 | 4.616 |
201806 | 1.880 | 106.317 | 2.330 |
201809 | 1.338 | 106.507 | 1.655 |
201812 | 0.650 | 105.998 | 0.808 |
201903 | 1.007 | 107.251 | 1.237 |
201906 | 1.082 | 108.070 | 1.319 |
201909 | 1.285 | 108.329 | 1.563 |
201912 | 1.173 | 108.420 | 1.426 |
202003 | 0.895 | 108.902 | 1.083 |
202006 | -0.004 | 108.767 | -0.005 |
202009 | 1.010 | 109.815 | 1.212 |
202012 | 0.531 | 109.897 | 0.637 |
202103 | 3.238 | 111.754 | 3.818 |
202106 | 3.168 | 114.631 | 3.642 |
202109 | 3.084 | 115.734 | 3.511 |
202112 | 2.932 | 117.630 | 3.285 |
202203 | 2.607 | 121.301 | 2.832 |
202206 | 2.439 | 125.017 | 2.571 |
202209 | 2.180 | 125.227 | 2.294 |
202212 | 1.927 | 125.222 | 2.028 |
202303 | 1.595 | 127.348 | 1.650 |
202306 | 1.290 | 128.729 | 1.321 |
202309 | 1.072 | 129.860 | 1.088 |
202312 | 0.849 | 129.419 | 0.864 |
202403 | 0.776 | 131.776 | 0.776 |
Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Thank you for viewing the detailed overview of Ekso Bionics Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Jerome Wong | officer: Interim CFO | C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804 |
Scott G. Davis | officer: President & COO | C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804 |
Steven Sherman | director | |
Jason C Jones | officer: VP of Product Development | EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804 |
John Glenn | officer: Chief Financial Officer | 7900 HOPYARD ROAD, APT 210, PLEASANTON CA 94577 |
Lathan Corinna | director | 140 KENDRICK STREET, NEEDHAM MA 02494 |
William R Shaw | officer: See Remarks | 1414 HARBOUR WAY SOUTH, SUITE 1201, C/O EKSO BIONICS HOLDINGS, INC., RICHMOND CA 94804 |
Rhonda A. Wallen | director | C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804 |
Mary Ann Cloyd | director | 184 LIBERTY CORNER ROAD, SUITE 302, WARREN NJ 07059 |
Combest Development (hong Kong) Ltd | 10 percent owner | ROOM 2210, CC WU BUILDING 302, HENNESSY ROAD, WAN CHAI, HONG KONG K3 999077 |
Jack Peurach | director, officer: Chief Executive Officer | 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804 |
Thomas A Schreck | director | 10240 BUBB RD, CUPERTINO CA 95014 |
Puissance Capital Management Lp | 10 percent owner | 950 THIRD AVENUE, 25TH FLOOR, NEW YORK NY 10022 |
Christian Babini | officer: VP of Sales, Americas | C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1, RICHMOND CA 94804 |
Puissance Cross-border Opportunities Ii Llc | 10 percent owner | C/O PUISSANCE CAPITAL FUND (GP) LLC, 950 THIRD AVENUE, NEW YORK NY 10022 |
From GuruFocus
By sperokesalga sperokesalga • 04-27-2023
By PRNewswire • 12-14-2023
By PRNewswire PRNewswire • 06-23-2022
By sperokesalga sperokesalga • 02-23-2023
By GuruFocusNews GuruFocusNews • 06-23-2022
By PRNewswire PRNewswire • 07-13-2022
By PRNewswire PRNewswire • 07-03-2022
By PurpleRose PurpleRose • 07-15-2022
By Value_Insider Value_Insider • 10-27-2022
By Marketwired • 09-11-2023